Combination of saikosaponin c and telbivudine synergistically enhances the anti-HBV activity
- 20 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammation Research
- Vol. 69 (6), 545-547
- https://doi.org/10.1007/s00011-020-01336-y
Abstract
Objective The present study was undertaken to obtain data using the combination of SSc and lamivudine (LAM), entecavir (ETV) or telbivudine (LdT) in HepG2.2.15 cells to explore whether SSc acts as a potent adjuvant of nucleoside analogues in anti-HBV treatment. Methods HepG2.2.15 cells were incubated with either SSc combined with any one of three nucleoside analogues (NAs) LAM, ETV, LdT or only one of them for 48 h. The expression profiles of HBV DNA, HBsAg, HBeAg, and HBcAg were examined by real-time quantitative PCR, ELISA, and western blot. Results Compared with mono-drug treatment, the combination of SSc and any of the three nucleoside analogues significantly promoted additional reduction on HBV DNA level. Declined levels of HBsAg, HBeAg, and HBcAg were observed in SSc and LdT combination group. Conclusion These in vitro results indicated that SSc acted as a promising nucleoside analogue adjuvant, especially for telbivudine in the therapeutic strategies against HBV infection.Keywords
Funding Information
- Sanming Project of Medicine in Shenzhen (SZSM201512005)
This publication has 9 references indexed in Scilit:
- Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesisInflammation Research, 2019
- Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transportersOncotarget, 2017
- New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A ReviewInfectious Diseases and Therapy, 2017
- Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis BCold Spring Harbor Perspectives in Medicine, 2015
- Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyJournal of Hepatology, 2014
- Metabolism of Saikosaponin a in Rats: Diverse Oxidations on the Aglycone Moiety in Liver and Intestine in Addition to Hydrolysis of Glycosidic BondsDrug Metabolism and Disposition, 2012
- Benefits and risks of combination therapy for hepatitis BHepatology, 2009
- A robustness-based approach to systems-oriented drug designNature Reviews Drug Discovery, 2007
- Effect of Sho-saiko-to (Xiao-Chai-Hu-Tang) on HBeAg Clearance in Children with Chronic Hepatitis B Virus Infection and with Sustained Liver DiseaseThe American Journal of Chinese Medicine, 1991